Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Prescription drug costs drive spike in St. Mary Parish school health claims, district staff warn
Summary
District staff told the St. Mary Parish School Board that prescription drug spending, driven by GLP-1 medications and a new specialty biologic, produced a June claims spike that could raise the district's 2026 renewal rates.
Mister Perez, a district staff member, told the St. Mary Parish School Board on July 10 that the district paid $1,100,000 in health insurance premiums and $1,448,000 in claims through June 2025, with June recording the largest single-month prescription drug spend at $608,000.
Perez said two drugs account for most of the increase: a GLP-1 medication (referred to in the presentation as Mangero) and a new specialty biologic advertised as "SKYRIZI On Body Injectable." "Mangero accounts for an increase of 201,000 dollars," Perez said, and the new specialty drug "represents a cost of a $155,000." He added that together those two drugs…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
